Notice of Annual General Meeting 2021
Please join us on October 23rd from 10:00-11:30am for our AGM and a presentation on how drugs come to market to Canada.
NOTICE OF ANNUAL GENERAL MEETING 2021
TO: The Members of the Tumour Foundation of BC (the “Society”)
NOTICE IS HEREBY GIVEN, pursuant to the Society Act of British Columbia (the “Act”) and the Bylaws of the Society, that the 2021 Annual General Meeting of the Society will be held on October 23rd 10:00am to 11:30am for the following purposes:
- To receive the President and Executive Director report
- To receive the financial report for the year ended June 30, 2021
- Election of Directors
- Appointment of Auditor
- Other Business.
In April 2020 the first drug for treating plexiform tumours in NF1 was approved in the United States. Approval of the drug in Europe followed in June 2021. When will Koselugo be available to the NF community in Canada? Come join us for this meeting to learn more.
